WHO ICTRP trial
Comparing the effectiveness of Apatinib combined with Paclitaxel For Injection…
ChiCTR1800020401 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800020401 |
|---|---|
| Public title | Comparing the effectiveness of Apatinib combined with Paclitaxel For Injection (Albumin Bound) and Tegafur and Paclitaxel For Injection (Albumin Bound) combined with?Tegafur neoadjuvant therapy for resectable, locally advanced pancreatic cancer patients: A prospective, open-label clinical trial. |
| Scientific title | Comparing the effectiveness of Apatinib combined with?Paclitaxel For Injection (Albumin Bound) and Tegafur and Paclitaxel For Injection (Albumin Bound) combined with?Tegafur neoadjuvant therapy for resectable, locally advanced pancreatic cancer patients: A prospective, open-label clinical trial. |
| Primary sponsor | Affiliated Cancer Hospital of Harbin Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | Possible removal of locally advanced pancreatic cancer |
| Interventions | Group 1:Tegafur, Paclitaxel-albumin and apatinib;Group 2:Tegafur, Paclitaxel-albumin |
| Registration date | Dec 28, 2018 |
| Target size | Group 1:30;Group 2:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: